Intraoperative Radiation Therapy Market

ZEISS (Germany) and iCAD, Inc (US) are Leading Players in the Intraoperative Radiation Therapy Market

The global intraoperative radiation therapy market is projected to reach USD 68 million by 2024 from USD 48 million in 2019, at a CAGR of 7.0%. Growth in the intraoperative radiation therapy market can be attributed to factors such as the rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players. However, the complex nature of technology coupled with a shortage of trained personnel and reluctance of physicians to use IORT owing to reimbursement coverage are the major factors that are expected to restrain the growth of this market.

The major players operating in the intraoperative radiation therapy market include ZEISS Group (Germany) and iCAD, Inc. (US). Other players in this market include IntraOp Medical Corporation (US), Ariane Medical Systems, Ltd. (UK), Sordina IORT Technologies S.p.A. (Italy), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US) Elekta AB (Sweden), Varian Medical Systems, Inc. (US), and Eckert & Ziegler Group (Germany). The analysis of the market developments between 2016 and 2019 revealed that several growth strategies such as product launches & enhancements and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the intraoperative radiation therapy market. Among these business strategies, product launches and approvals were the most widely adopted growth strategies by market players.

To know about the assumptions considered for the study download the pdf brochure

ZEISS (Germany) is among the pioneer companies that combined surgery with radiotherapy to develop and introduce the intraoperative radiation therapy to the cancer treatment field. The flagship product of the company—INTRABEAM is one of the most widely used IORT products across the globe. INTRABEAM is a revolutionary, intraoperative form of radiation therapy for early-stage breast cancers. Because INTRABEAM allows radiation treatment and breast-conserving surgery to be performed simultaneously, the need for several weeks of external radiation therapy following surgery can often be minimized or eliminated. The strong foothold of the company in the IORT market can be attributed to its wide geographic reach. ZEISS is present in around 50 countries, such as China, France, Germany, India, the UK, and the US. The company has more than 30 production sites, around 60 sales & service locations, and 25 R&D facilities. ZEISS has a sound custom services support set up, which helps it to strengthen its customer relationships and presence in the market.

iCAD, Inc (US) is one of the major players in the intraoperative radiation therapy market. The company offers a wide range of IORT products, including electronic brachytherapy products, different types of applicators, and accessories. In the last three years, the company has significantly invested in R&D activities, to upgrade its existing and launch advanced products in the market. In 2018, the R&D expenses accounted for 37.5% (USD 10 million) of the company’s total revenue.

Related Reports:

Intraoperative Radiation Therapy Market by Method (Electron IORT, Intraoperative Brachytherapy), Products & Services (Accelerators, Treatment Planning System, Applicators, Afterloaders, Accessories), Application (Breast, Brain) - Global Forecasts to 2024

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
MD 7339
RI Published ON
9/4/2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Intraoperative Radiation Therapy Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved